in human spermatozoa, which essentially renders them unable to fertilise oocytes.
To counteract high levels of ROS, cells generally rely on various intrinsic and extrinsic antioxidant mechanisms. Endogenous antioxidants consist of enzymatic antioxidants such as SOD, catalase, thiol peroxidases and non-enzymatic antioxidants such as glutathione. In contrast, exogenous antioxidants consist of micronutrients such as vitamin A, vitamin C, vitamin E, L-carnitine, N-acetyl cysteine as well as trace elements such as selenium and zinc (Halliwell & Gutteridge, 1989) , which have to be exogenously provided to the body in order to maintain a fine balance between oxidation and reduction (anti-oxidation) in any living cell (Valko et al., 2007) .
Many people are living an unhealthy lifestyle leading to obesity, which causes a systemic inflammatory response, elevated production of adipokines, cytokines and high levels of ROS (Kahn & Brannigan, 2017; Tsatsanis et al., 2015) . In addition, exposure to toxicants including smoking, alcohol, radiation or environmental pollutants (Mathur, Huang, Kashou, Vaithinathan, & Agarwal, 2011; Sharma, Biedenharn, Fedor, & Agarwal, 2013 ) also results in oxidative stress. Clinically, physicians usually prescribe antioxidant supplements to treat oxidative stress-related disorders, including cases of male infertility. In addition, many patients take additional overthe-counter antioxidants because these compounds are regularly portrayed as promoters of good health as they are able to "combat" ageing and diseases. These supplements usually contain relatively high concentrations of few selected, purified antioxidants such as vitamin C and E and lycopene. Furthermore, many commonly available food products are already supplemented with vitamins and antioxidants. Consequently, it is possible for patients to inadvertently end up taking very high doses, or even too high doses of such antioxidants (Poljsak, Šuput, & Milisav, 2013) .
On the other hand, antioxidant supplementation has not shown consistent beneficial outcomes. Moreover, certain studies have even described the harmful effects of antioxidant intake. For instance, vitamin E at higher doses has been shown to increase all-cause mortality in patients (Miller et al., 2005) . Further, it is well known that vitamin A supplementation does not have anti-cancer effects, but rather the opposite effect is seen in smokers (AlphaTocopherol, Beta Carotene Cancer Prevention Study Group, 1994) .
Low vitamin C intake is associated with elevated oxidative stress and DNA damage (Fraga et al., 1991) . Nonetheless, administration of high ascorbate concentrations has also been shown to exert the same effects by causing oxidative stress (Aruoma, Halliwell, Gajewski, & Dizdaroglu, 1991) . Halliwell (2000) referred to this paradoxical effect of antioxidants as the "antioxidant paradox."
Essentially, these contradictory effects highlight the fact that ROS generation and scavenging thereof by means of antioxidants is critical for normal bodily and cellular function, including that of male fertility. Thus, a fine balance between oxidation and reduction is essential to maintain this equilibrium (Figure 1 ) (de Lamirande & Gagnon, 1995; Henkel, 2011; Kothari, Thompson, Agarwal, & Plessis, 2010) . Consequently, exposure to high levels of oxidants will cause a status of oxidative stress, which is well described and established as a major cause of male infertility (Agarwal, Makker, & Sharma, 2008) .
In contrast, uncontrolled, unphysiologically high exposure to antioxidants (reductants) will also have significant negative effects on cells and male fertility; this might not be an exception. A shift of the bodily redox levels into a more reduced state is called "reductive stress." Reportedly, reductive stress is regarded as dangerous as oxidative stress (Castagne, Lefevre, Natero, Clarke, & Bedker, 1999) .
In other medical fields such as neuroscience or cardiology, this concept of reductive stress has already been embraced to explain specific diseases and pathologies. Despite signs being available, however, this has not been evaluated in Andrology so far. Therefore, this brief article will discuss the overall effects of antioxidants in male infertility and the possible risks involved that may lead to a state of reductive stress or oxidative stress through the "antioxidant paradox.".
| ANTI OXIDANTS AND MALE INFERTILIT Y
Since high levels of ROS are thought to cause various diseases including male infertility, the apparent logical solution to this condition F I G U R E 1 Redox balance; effects of oxidants and antioxidants. While among others, oxidative stress (a) is a cause of ageing, neurodegenerative diseases and infertility, reductive stress (c) can be a cause of cancer, cardiomyopathy, blood-brain-barrier dysfunction and infertility. Optimal physiological functions are carried out at balanced redox levels (b) is to assume that an increased antioxidant intake will not only help treat male infertility but also prevent it from occurring. Antioxidants, in various formulations containing selected antioxidants at different concentrations, are readily available over-the-counter in the form of dietary supplements and are also commonly added to various food products and teas (Finley et al., 2011) . In terms of male infertility, glutathione, vitamins C and E, carnitine, N-acetyl cysteine, co-enzyme-Q10, selenium and zinc are among the commonly used antioxidants as a treatment, although exact dosages and regimens have not been clearly defined (Agarwal & Majzoub, 2016; Agarwal, Nallella, Allamaneni, & Said, 2004) . As a result, the studies conducted thus far were rather heterogeneous in both design and outcomes. Table 1 At the same time, various in vivo and randomised control trials have failed to show positive outcomes on semen parameters and some have even reported negative outcomes in terms of increased sperm DNA fragmentation or chromatin decondensation (Table 2) .
A meta-analysis by Showell et al. (2014) examined the low-quality evidence that was available at that point of time from only four small randomised, controlled trials and concluded that antioxidant treatment may increase pregnancy and live birth rates. In addition, antioxidant supplementation appeared not to increase the risk of miscarriage. Consequently, larger randomised, placebo-controlled studies are necessary in order to come up with recommendations that are more concrete. In one recent single-centre, randomised, double-blind, placebo-controlled trial including 104 subjects with and without varicocele, who were supplemented for 6 months with L-carnitine, acetyl-L-carnitine and other micronutrients, revealed that sperm concentration and motility improved significantly in both patient groups (Busetto et al., 2018) . In another prospective, randomised study by Bozhedomov et al. (2017) , the authors co-administered L-and acetyl-L-carnitine, clomiphene citrate with vitamins and minerals to patients with idiopathic male infertility. Results show increased sperm concentration in patients with multiple sperm defects (oligoasthenoteratozoospermia). Contrary, progressive motility, normal sperm morphology and pregnancy rates, however, did not improve.
TA B L E 1 Antioxidants and their use in treatment of male infertility
Male and female reproductive systems protect spermatozoa from ROS-induced damage (Holt & Fazeli, 2016) and also modulate sperm functions, for example, in terms of sperm storage in the female reproductive tract or gamete interaction (Agarwal, Gupta, & Sharma, 2005; Holt & Fazeli, 2016) . In the rat, it was shown that changes in the antioxidant levels in the female reproductive tract may have significant implications on the fertilisation process itself (Behr et al., 2009 ). Moreover, higher antioxidant levels in follicular fluid in patients undergoing in vitro fertilisation (IVF) indicate that these patients may have better chances of becoming pregnant (Huang et al., 2014; Ozkaya & Nazıroglu, 2010) . On the other hand, an increased, Flora, L-lysine, and Moducare). According to the report of the wife, all these supplements were taken together. After discontinuing the antioxidant intake in both partners for 3 months, the wife became spontaneously pregnant (Henkel, unpublished observation) . In this particular case, one can only speculate if high antioxidant levels led to male infertility or negatively affected implantation or early embryo development. However, this case illustrates the possible detrimental effects of high antioxidant activities in both male and female.
| THE ANTI OXIDANT PAR ADOX AND NOTAB LE ADVER S E EFFEC TS
The fact remains that on the one hand, ROS play an important role in the pathogenesis of several human diseases, but on the other hand, large doses of antioxidative supplements have produced conflicting results that have lead researchers to coin the term "antioxidant paradox" (Halliwell, 2000) . This highlights the poor understanding of the exact mechanisms involved in administering antioxidant therapy.
It appears that current antioxidant therapies to treat male infertility may be based on a misleading assumption that antioxidants in general are healthy, leading to the use of a wrong composition of the antioxidant treatment. In fact, specific negative effects have been reported for many of the usually recommended antioxidants such as selenium or vitamins C and E (Menezo et al., 2014) . Taking selenium as an example, no deficiency has yet been described in the scientific literature. Furthermore, increased seminal plasma levels of selenium (≥80 ng/ml) were reported to be associated with decreased motility, asthenozoospermia and elevated abortion rates, whereas selenium levels between 40 and 70 ng/ml were reported to be optimal for reproductive performance (higher pregnancy rates and lower abortion rates) (Bleau, Lemarbre, Faucher, Roberts, & Chapdelaine, 1984) . In addition, there is increasing evidence that the antioxidant or pro-oxidant activities of antioxidants, even if they are deriving from natural sources, ultimately depend on their concentration (Bouayed & Bohn, 2010) . Moreover, since many of the antioxidant plant compounds act synergistically, antioxidant treatment will not only fail, but may even be toxic, if the relevant synergistic compound is absent. This could be seen in smokers supplemented with 20 mg/day β-carotene (Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group, 1994) or 30 mg β-carotene and 25,000 IU retinyl palmitate per day (Omenn et al., 1996) as this treatment significantly increased the risk of lung cancer in an efficacy trial against a placebo in 29,133 and 18,314 subjects respectively.
Additionally, various animal studies and clinical observations
have indicated that high doses of antioxidants can produce adverse effects. These effects may be the result of imbalances in the physiological redox status either resulting oxidative stress through the phenomenon of the "antioxidant paradox" or in reductive stress (Wendel, 1987) , which can be as detrimental to cells or the organism as oxidative stress, by causing cellular dysfunction (Castagne et al., 1999) . Some of these adverse effects include cancer, cardiomyopathy, blood-brain barrier dysfunction, Alzheimer's disease or even embryogenesis defects (Fisher & Mentor, 2017; Klein et al., 2011; Lloret, Fuchsberger, Giraldo, & Vina, 2016; Rajasekaran et al., 2007; Ufer, Wang, Borchert, Heydeck, & Kuhn, 2010; Wang & Rogers, 2007) .
In human reproduction, Ufer et al. (2010) stated that the cellular redox system has to be tightly controlled as the proper equilibrium between oxidation and reduction is fundamental for normal embryogenesis. Consequently, too high levels of antioxidants may induce teratogenic developments (Wang & Rogers, 2007) leading to changes in the activity of redox-sensitive transcription factors and subsequently altered gene expression patterns (Harvey, Kind, & Thompson, 2002) . As a result, developmental retardation and malformations may occur. On the other hand, at implantation, the developing embryo is faced with an almost anoxic milieu (Leese, 1995) , highlighting the narrow range of this redox balance for living cells.
Specifically in andrology, a study conducted by Menezo et al., 2007 ) assessed daily oral antioxidant treatment with vitamins C and E (400 mg each), β-carotene (18 mg), zinc (500 μmol) and selenium (1 μmol) in men whose female partners failed to become pregnant after IVF/ICSI. After therapy, sperm DNA damage decreased but sperm DNA decondensation increased, which can result in asynchronous chromosome condensation. DNA decondensation rates of more than 28% were shown to cause pregnancy failure in IVF and ICSI patients. The study concluded that increased DNA decondensation may be caused by the ability of vitamin C to break disulphide bonds in protamines in sperm DNA as this vitamin has the capacity to open the S-S-bonds of protamines (Donnelly, McClure, & Lewis, 1999; Giustarini, Dalle-Donne, Colombo, Milzani, & Rossi, 2008) . Ultimately, reduction in the protamines will lead to nuclear decondensation problems and decreased fertility (Menezo et al., 2007) .
In an earlier in vitro analysis, positive and negative dose-related effects of vitamin C on sperm motility and sperm membrane lipid peroxidation have been observed. Vitamin C at concentrations below 1,000 μM resulted in increased sperm motility and decreased lipid peroxidation, while concentrations above 1,000 μM have shown the complete opposite effect with complete sperm immobility at concentrations above 4,000 μM (Verma & Kanwar, 1998) . These studies show the paradoxical effects of antioxidants in the treatment of male infertility, which appear to be dose-dependent (Tables 1 and 2 ). However, one could also think that the composition of a specific antioxidant mixture, as it is given in var- are not only taking antioxidants as they are made to believe that antioxidants are good for anti-ageing and the body in general, and furthermore treated by clinicians for male infertility because it is thought that oxidative stress is detrimental in particular.
Considering that our modern lifestyle with a lack of vitamin intake, exposure to environmental toxicants and/or smoking leaves the body rather in a state of oxidative stress. Consequently, treatment with antioxidants can help to alter this state. However, an unspecific and uncontrolled antioxidant intake might flood the body with antioxidants leading to reductive stress and causing infertility.
Therefore, more efforts in investigating the redox status, its influence on the fertilisation process in general and sperm functional capacity specifically have to be undertaken. In the meantime, where no guidelines are available, clinicians should carefully examine and interview patients more thoroughly before they prescribe additional antioxidants in order to avoid the possibility of the patients overdosing on antioxidants causing reductive stress.
| CON CLUS ION
The use of antioxidant therapy to treat OS-induced male infertility has been shown to have positive effects on semen parameters in some men, but not all. It is possible that in some studies, the role of OS as the cause of male infertility was overestimated as the patients' redox status was not accurately assessed before initiating the treatment. As a result, administration of exogenous antioxidants may instead either lead to oxidative stress induced by the "antioxidant paradox" or reductive stress with decreases in endogenous oxidants that are essential for the induction of physiological pathways resulting in an inhibition of these functions such as sperm capacitation.
Hence, it emerges that antioxidants appear to have not only beneficial effects, but also significant adverse effects, if antioxidants are taken in excess or if synergistic compounds are lacking. Therefore, the consumption of antioxidants needs to be considered with caution and patients should be tested for their redox status before treating them with a specifically formulated supplement. Clearly, when treatment is indicated, it must be individualised to each patient once his normal redox status has been established. Further research is urgently needed to better define the benefits of antioxidant therapy, optimal doses and the possible risks involved.
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